PF-4455242
PF-4455242 is a drug developed by Pfizer for the treatment of Cognitive disorders. It acts as a potent and selective inhibitor of the enzyme nitric oxide synthase 1 (nNOS), which is responsible for the production of nitric oxide in the brain. Nitric oxide acts as a neurotransmitter and has a role in the regulation of neuronal plasticity, learning, and memory. Inhibition of nNOS is therefore being investigated as a potential treatment for conditions such as Alzheimer's disease and schizophrenia.
Development and Clinical Trials[edit | edit source]
PF-4455242 was developed by Pfizer as part of their research into treatments for cognitive disorders. It was selected for development due to its potent and selective inhibition of nNOS, which is thought to have potential benefits in the treatment of conditions such as Alzheimer's disease and schizophrenia.
Clinical trials of PF-4455242 have been conducted to assess its safety, tolerability, and efficacy in humans. These trials have provided valuable data on the drug's pharmacokinetics and pharmacodynamics, as well as its potential therapeutic effects.
Mechanism of Action[edit | edit source]
PF-4455242 acts by inhibiting the enzyme nNOS, which is responsible for the production of nitric oxide in the brain. Nitric oxide acts as a neurotransmitter and has a role in the regulation of neuronal plasticity, learning, and memory. By inhibiting nNOS, PF-4455242 may help to regulate these processes and improve cognitive function.
Potential Therapeutic Applications[edit | edit source]
The potential therapeutic applications of PF-4455242 are primarily in the treatment of cognitive disorders such as Alzheimer's disease and schizophrenia. These conditions are characterized by impairments in cognitive function, which may be related to dysregulation of nitric oxide signaling in the brain. By inhibiting nNOS, PF-4455242 may help to restore normal cognitive function in these conditions.
See Also[edit | edit source]
| PF-4455242 Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
